WhatsApp is updating its mobile apps for a fresh and more streamlined look, while also introducing a new “darker dark mode,” the company announced on Thursday. The messaging app says that over…
Texas Monthly – Ken Paxton Mistakes Catholic Teachings for “Bohemian Commandments”
It’s Ken Paxton versus Catholics, round two. Back in February, the Texas attorney general targeted the migrant shelter Annunciation House, in El Paso, on his stated suspicions of “alien harboring” and “operating…
Texas Monthly – Two political consultants plead guilty in Henry Cuellar bribery case
The Laredo Democrat faces federal charges of bribery, money laundering and working on behalf of a foreign government. Read: Read More
Texas Tribune Two political consultants plead guilty in Henry Cuellar bribery case
The Laredo Democrat faces federal charges of bribery, money laundering and working on behalf of a foreign government. Read: Read More
Texas Tribune Two political consultants plead guilty in Henry Cuellar bribery case
The Laredo Democrat faces federal charges of bribery, money laundering and working on behalf of a foreign government. Read: Read More
Tech Crunch – Google I/O 2024: How to watch
The keynote kicks off at 10 a.m. PT on Tuesday and will offer glimpses into the latest versions of Android, Wear OS and Android TV. © 2024 TechCrunch. All rights reserved. For…
Texas Monthly – Texas to reimburse landowners for damages caused by border property crime
Lawmakers created the program during last year’s legislative session. Read: Read More
Texas Tribune Texas to reimburse landowners for damages caused by border property crime
Lawmakers created the program during last year’s legislative session. Read: Read More
Texas Tribune Texas to reimburse landowners for damages caused by border property crime
Lawmakers created the program during last year’s legislative session. Read: Read More
Tech Crunch – Triomics raises $15M Series A to automate cancer clinical trials matching
For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients…